ABT · 10-Q · 2026Q2 · Full report
Supply Chain and Inventory
ABBOTT LABORATORIES · 2026-07-28 · Importance 48 · Surprise 40 · From source text
Total inventories increased 12.7% to $7.315 billion at June 30, 2026, from $6.488 billion at December 31, 2025, exceeding the materiality threshold and indicating a significant build in materials and finished products. Finished products increased to $4.512 billion from $3.976 billion, while materials rose to $1.780 billion from $1.608 billion. The filing does not identify specific supplier constraints, lead-time changes, or product shortages associated with the inventory increase.
Key facts
- Trade receivables at June 30, 2026: $8,599 million and at December 31, 2025: $7,929 million (net of allowances).
- Total inventories at June 30, 2026: $7,315 million.
- Total inventories at December 31, 2025: $6,488 million.
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| assets | positive | realized | +0.6% | Trade receivables at June 30, 2026: $8,599 million and at December 31, 2025: $7,929 million (net of allowances). |